NFYC2: A Potential Drug Target Or Biomarker (G494127)

Target Name: NFYCP2

NCBI ID: G494127

NFYCP2

Other Name(s): NFYC pseudogene 2

NFYC2: A Potential Drug Target Or Biomarker

The NFYC pseudogene 2 (NFYC2) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The NFYC family of genes plays a role in the development and maintenance of normal tissues, and research has suggested thatNFYC2 may be involved in a variety of physiological processes.

One of the key features ofNFYC2 is its role in cell signaling. NFYC2 has been shown to play a role in the regulation of cell growth, differentiation, and survival. It has been shown to interact with a variety of signaling pathways, including the TGF-β pathway and the Wnt pathway.

In addition to its role in cell signaling, NFYC2 has also been shown to be involved in the regulation of cellular processes that are important for tissue development and homeostasis. For example, research has suggested that NFYC2 may be involved in the development of tissues that are important for the development of organs, such as the liver and the pancreas.

Due to its involvement in these processes, NFYC2 has been identified as a potential drug target or biomarker for a variety of diseases. For example, research has suggested thatNFYC2 may be a potential target for the treatment of cancer, as it has been shown to play a role in the regulation of cellular processes that are important for tumor growth and progression.

In addition to its potential as a drug target or biomarker, NFYC2 has also been shown to have potential as a diagnostic tool. For example, research has suggested that NFYC2 may be expressed in a variety of tissues and cells, and that it may be a useful biomarker for the diagnosis of certain diseases.

Overall, the NFYC pseudogene 2 is a promising candidate for as a drug target or biomarker. Further research is needed to fully understand its role in these processes and to determine its potential as a therapeutic intervention.

Protein Name: NFYC Pseudogene 2

The "NFYCP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NFYCP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets